Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Implementation of an NGS-based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignancies.
Levy MA, Santos S, Kerkhof J, Stuart A, Aref-Eshghi E, Guo F, Hedley B, Wong H, Rauh M, Feilotter H, Berardi P, Semenuk L, Yang P, Knoll J, Ainsworth P, McLachlin CM, Chin-Yee I, Kovacs M, Deotare U, Lazo-Langner A, Hsia C, Keeney M, Xenocostas A, Howlett C, Lin H, Sadikovic B. Levy MA, et al. Among authors: berardi p. Eur J Haematol. 2019 Sep;103(3):178-189. doi: 10.1111/ejh.13272. Epub 2019 Jul 30. Eur J Haematol. 2019. PMID: 31177553
Nelarabine-containing regimen followed by daratumumab as an effective salvage therapy and bridge to allogeneic hematopoietic stem cell transplantation for primary refractory early T-cell precursor lymphoblastic leukemia.
Fulcher J, Berardi P, Christou G, Villeneuve PJA, Bredeson C, Sabloff M. Fulcher J, et al. Among authors: berardi p. Leuk Lymphoma. 2021 Sep;62(9):2295-2297. doi: 10.1080/10428194.2021.1901097. Epub 2021 Mar 21. Leuk Lymphoma. 2021. PMID: 33749497 No abstract available.
Systematic Scoping Review of Studies Reporting Unexpected Donor-Derived Abnormalities from Recipients of Allogeneic Hematopoietic Cell Transplantation: A Proposed Framework for Donor Disclosure.
Candeliere J, Kirkham AM, Shorr R, Morris G, Berardi P, Seftel MD, Allan DS. Candeliere J, et al. Among authors: berardi p. Transplant Cell Ther. 2022 Jul;28(7):408.e1-408.e8. doi: 10.1016/j.jtct.2022.03.029. Epub 2022 Apr 8. Transplant Cell Ther. 2022. PMID: 35398578 Free article.
Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial.
Bégin P, Callum J, Jamula E, Cook R, Heddle NM, Tinmouth A, Zeller MP, Beaudoin-Bussières G, Amorim L, Bazin R, Loftsgard KC, Carl R, Chassé M, Cushing MM, Daneman N, Devine DV, Dumaresq J, Fergusson DA, Gabe C, Glesby MJ, Li N, Liu Y, McGeer A, Robitaille N, Sachais BS, Scales DC, Schwartz L, Shehata N, Turgeon AF, Wood H, Zarychanski R, Finzi A; CONCOR-1 Study Group; Arnold DM. Bégin P, et al. Nat Med. 2022 Jan;28(1):212. doi: 10.1038/s41591-021-01667-1. Nat Med. 2022. PMID: 35022578 Free PMC article. No abstract available.
Weak D type 67 in four related Canadian blood donors.
Berardi P, Bessette E, Ng M, Angus N, Lane D, Gariepy L, Pavenski K, Ochoa-Garay G, Cote J, Goldman M. Berardi P, et al. Immunohematology. 2015;31(4):159-62. Immunohematology. 2015. PMID: 27187196
79 results